OptiNose - 53 Year Dividend History | OPTN
Historical dividend payout and yield for OptiNose (OPTN) since 1971. The current TTM dividend payout for OptiNose (OPTN) as of November 20, 2024 is $0.00. The current dividend yield for OptiNose as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.060B |
$0.071B |
|
OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
